Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears

Equality Impact Assessment (Guidance development) (PDF 171 KB)

Final appraisal determination

Committee papers (PDF 3.18 MB)

Final appraisal determination document (PDF 409 KB)

Appraisal consultation

Appraisal consultation document (PDF 543 KB)

Committee papers information

Committee papers (PDF 7.13 MB)

Dry eye disease - ciclosporin: equality impact assessement scoping (PDF 62 KB)

Dry eye disease - ciclosporin: NICEs response to comments on the draft scope and provisional matrix (PDF 210 KB)

Dry eye disease - ciclosporin: final matrix (PDF 32 KB)

Dry eye disease - ciclosporin: final scope (PDF 33 KB)

Dry eye disease - ciclosporin: provisional matrix (pre-referral) - November 2013 (PDF 40 KB)

Dry eye disease - ciclosporin: draft scope for consultation (pre-referral) - November 2013 (PDF 101 KB)